BAC vs DHR: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
Bank of America Corporation · Financial Services
$59.50
-45.0% upside to fair value
Grade C
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
BAC trades at a lower forward P/E
(14.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BAC |
DHR |
| Current Price |
$59.50 |
$195.98 |
| Fair Value Estimate |
$32.73 |
$211.54 |
| Upside to Fair Value |
-45.0%
|
+7.9%
|
| Market Cap |
$422.2B |
$138.7B |
| Forward P/E |
14.6x
|
37.8x
|
| EV / EBITDA |
13.3x
|
22.8x
|
| Price / Sales |
2.4x
|
5.6x
|
| Price / FCF |
7.5x
|
26.2x
|
| Revenue Growth YoY |
-35.6%
|
+3.7%
|
| Gross Margin |
63.2%
|
60.7%
|
| Operating Margin |
22.9%
|
21.0%
|
| Return on Equity |
10.5%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
13.4%
|
3.81%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Bank of America Corporation operates as a diversified bank within the financial services sector, offering a broad range of banking and financial products. The business quality is medium, supported by a 10.5% return on equity and solid margins, but recent revenue declined sharply by 35.6% in the most recent quarter, indicating top-line pressure. Despite earnings growth of 16.1% in the same period,…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
BAC |
DHR |
| Zone Low |
$24.55 |
$158.66 |
| Zone High |
$27.82 |
$179.81 |
| In Buy Zone? |
No
|
No
|